A Group-Based Approach To Medication-Assisted Treatment For Opioid Use Disorders is organized by American Psychiatric Association (APA). This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credit™.
Program Begin Date:- Jun 08, 2015.
Program End Date:- Dec 31, 2020.
This program is designed for physicians who have a waiver to treat opioid dependence in an office-based setting and other interested clinicians.
West Virginia has been particularly hard hit by the current opioid epidemic and consistently ranks as one of the top two states suffering from opioid overdose and addiction. We describe our experience in the evolution of a sustainable treatment program using buprenorphine in providing medical and psycho-educational groups that are chronologically tied together. This model, which also includesindividual counseling and twelve step participation, moves participants through three “stages” of treatment: Beginning, Intermediate, and Advanced. Since 2004 we have treated more than 2000 patients and currently are providing care for 400 patients on-site (including 30-35 pregnant patients) and another 40 patients via tele-buprenorphine clinics. Treatment is open ended and the average time in clinic is 33 months. We believe this model is highly effective in keeping patients therapeutically engaged and increasing the quality of life for those suffering from the disease of addiction.
• Briefly describe the opioid epidemic in West Virginia
• Discuss the historical development of the WV model of using group addiction treatment bup/nx
• Describe the components of the WV Model
• Identify the benefits of chronologically linking bup/nx treatment with addiction psychoeducational treatments using a group model
• Identify short term and long term challenges in using this model.